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Resistance to reinfection withSchistosoma mansoni has been demonstrated in several
animal species including mice, rats, and rhesus monkeys (1-3). In the mouse, partial
immunity develops 10-12 wk after primary infection which appears to be directed against
the immature schistosomes (schistosomula) during the first few days oftheir development
in the host. Using an assay system in which schistosomula are counted on their journey
through the lungs, Sher et al. demonstrated that passive transfer of serum from partially
immune donors to normal recipients conveyed significant resistance to reinfection (4).
The mechanism of the serum-mediated response in vivo, and the possible role of effector
cells remain unknown.
In vitro systems for assaying immunologic activity against schistosomula have demon-
strated in the sera of infected humans (5), rhesus monkeys (6), rats (7), or guinea pigs (8)
antibodies which are either directly lethal to schistosomula or require neutrophils. In
addition, Butterworth et al. (9) have described killing of radiolabeled schistosomula on
incubation with decomplemented serum from schistosome-infected patients and normal
peripheral leukocytes from uninfected individuals. Preliminary observations have sug-
gested that maximum cytotoxicity was associated with eosinophil-rich polymorphonu-
clear leukocytes (9). This cytotoxicity was subsequently inhibited by the selective destruc-
tion of eosinophils with a monospecific rabbit antihuman eosinophil serum (10) supplied
by our laboratories (11).
The above findings stimulated the present series of experiments in which the
role of effector cells in acquired immunity to schistosomiasis in mice was studied
in vivo by the use of monospecific antileukocyte sera . Immune animals lost their
resistance to challenge infection when eosinophils-but not neutrophils-lym-
phocytes, or monocytes were depleted. Furthermore, the passive transfer of
resistance by immune sera was blocked when mice were treated with antieosino-
phil serum. These results suggest that an antibody-dependent eosinophil-me-





Youngadult female mice (18-22 g in weight) of the outbred CF-1 line were
obtained from Carworth Div., Becton, Dickinson & Co., New York. For induction of acquired
resistance, groups of mice were injected subcutaneously with 10 cercariae of S. mansoni
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obtained from a pool ofAustralorbis glabratus snails infected with a Puerto Rican strain of the
parasite (12) . Exposure to greater numbers of cercariae leads to high mortality from 10 wk of
infection on . Experiments on acquired resistance were done 16 and 32 wk after the animals were
infected . At the time of the challenge infection 90% of the 16-wk infected and 66% of the 32-wk
infected animals had primary bisexual infections as determined by finding eggs in their livers.
Those animals without eggs in the livers were discarded from the experiment .
Antisera . Monospecific antieosinophil serum (AES)' was prepared in rabbits injected subcuta-
neouslywith purified suspensions of mouseeosinophils in complete Freund's adjuvant as described
by Mahmoudet al . (13) . Rabbit antimouse neutrophil serum (ANS) was prepared by amodification
of the method described by Simpson and Ross (14) . Neutrophil-rich peritoneal exudates were
stimulated by injecting normal CF-1 mice intraperitoneally with 3 ml of 3% proteose peptone ; 15 h
thereafter the animals were similarly injected and the peritoneal exudate cells were harvested 3
hr later . Thecells were purified on a Hypaque density gradient (1 ml Hypaqueand 2.1 ml distilled
water), mixed with complete Freund's adjuvant, and injected into rabbits according to the protocol
described for the AES (13) . No cross-reactivity was detected betweenAES andANS in vitro or in
vivo (unpublished observations) .
Antimacrophage serum (AMS) wasraised in rabbits against mouse peritoneal macrophages as
described by Boros and Warren (15) . The antiserum used in these experiments was extensively
absorbed with lymphocytes . The antilymphocyte serum (ALS) used was raised against mouse
thymocytes in goats and was kindly provided by Dr . Mark A. Mandel of Case Western Reserve
University School of Medicine, Cleveland, Ohio (16) .
All antisera were administered intraperitoneally in doses of 0.25 ml starting 1 day before the
challenge infectionandcontinuing everyother day for five doses . Differential leukocyte counts on




Before examination of theresistance of infected immune mice to
challenge infection, the percentage recovery of schistosomula in groups of five normal CF-1 mice
was determined daily from day 4 to day 8; recovery was highest at day 6 .
Challenge infection wasdone by exposing individual mice to 500S. mansoni cercariae percuta-
neouslyas described previously (17) . Recovery of the schistosomula from the lungs wasperformed
as described by Sher et al . (2) and counts were performed in Sedgwick-Rafter chambers (Curtin-
Matheson Scientific, Cleveland, Ohio) at a magnification of 100.
Groups of five immune mice were used to study the effect ofAES on the recovery of schistoso-
mula 4, 6, and8 days after the challenge infection . Normal rabbit serum (NRS)was administered
to control groups . Recovery of schistosomula at day 6 was then used in comparing the effects of
AES to ALS, AMS, andANS in groups of five mice .
The effect of AES administration was also assayed by adult worm recovery . 32 wk after a
primary exposure to 10 S . mansoni cercariae, groups of six mice were challenged with 100
cercariae percutaneously as described above . Control mice received only primary or secondary
exposures . The challenged animals were treated with NRS or AES 1 day before the challenge
exposure and everyother day thereafter for five doses . 6 wk later, adult wormswere recovered by
perfusion of the portal circulation (17) and the livers were crushed between glass plates and
examined for residual worms and eggs . Large numbers of eggs revealed a primary bisexual
infection .
Passive Transfer of Immune Sera .
￿
Mice exposed to 10 cercariae ofS. mansoni were bled from
the retro-orbital plexus 16 wk after infection . Blood collected from a group of 20 infected animals
waspooled, allowed to clot at room temperature for 15 minandat 4°Cforan additional hour . The
tubeswere then centrifuged andtheserum collectedand stored at -20°Cuntilused . 10 uninfected,
nonimmune mice were bled in a similar manner to provide control serum. Four groups of six to
nine animals treated with NRS or AES received 0.5 ml of immune or nonimmune serum intra-
venously via a tail vein 1 day before challenge infection .
Results
Recovery of Schistosomula from the Lungs of Normal Mice and Effect of
'Abbreviations used in this paper: AES, antieosinophil ; ALS, antilymphocyte serum ; AMS,




Recovery of Schistosomula from the Lungs of Normal Control
Mice and those Treated with AES aftera Pereutaneous Exposure
to 500 S . mansoni Cercariae
AES .
￿
The number of schistosomula recovered from the lungs of normal mice
4-8 days after a percutaneous exposure to 500 cercariae is shown in Table 1. The
recovery increased from 15% at day 4 to 22% at day 6, and then declined to 8% at
day 8. The table also illustrates the effect of AES injections on the recovery of
schistosomula from the lungs of normal mice. No significant difference was
demonstrated at any point on the curve, and the pattern of recovery was similar
to control animals.
Recovery of Schistosomula from the Lungs of Immune Mice and Effect of
Antisera . After challenge exposure to 500 S. mansoni cercariae the recovery of
schistosomula from the lungs of mice with bisexual infections of 16 wk duration
was 40% less than previously uninfected control mice at 4 days (41 ± 2.4 vs. 73
6.1 schistosomula) and 38% less at 6 days (66 ± 3.9 vs. 108 ± 6.4 schistosomula).
Treatment of the 16-wk infected animals with AES abrogated their immunity
(Fig. 1) : the counts of schistosomula at 4, 6, and 8 days rose to or above the levels
seen in the previously uninfected animals (Table 1) and in each case were
significantly higher than those obtained from immune animals (P < 0.001). AES
treatment did not appear to alter the rate of migration of the schistosomula, as
the curves were similarto those seen in the untreated and NRS-treated animals
in which a decline in recovery of the organisms was seen at 8 days.The effect of
AES was also tested in a group of mice with bisexual infections of 32 wk
duration. In the NRS-treated animals the counts of schistosomula on day 6
averaged 69 ± 10.0; the corresponding figure in the AES-treated mice was 115 ±
8.0 (P < 0.01).
The effect of AES was then compared to that of antisera against other white
cell types. As shown in Table 11, AES, ANS, and ALS specifically reduced the
numbers of the corresponding cells in the peripheral blood. AMS virtually
eliminated peripheral monocytes, but also induced a moderate degree of lympho-
penia (Table II). Animals with bisexual S. mansoni infections of 16 wk duration
which were treated with NRS showed 40% fewer schistosomula 6 days after
challenge than previously uninfected mice . Recoveries of schistosomula from
previously infected animals treated with ALS, AMS, or ANS were similar to
those in the NRS-treated mice (Fig. 2). AES treatment, however, reversed the
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DAYS AFTER EXPOSURE TO CERCARIAE
Fir- 1 .
￿
Recovery of schistosomula from the lungs of partially immune mice treated with
NRS or AES 4, 6, and 8 days after percutaneous exposure to 500S . mansoni cercariae .
TABLE 11
Differential Leukocyte Counts after Percutaneous Infection with 500 Cercariae ofS .
mansoni of Control Uninfected Mice and Previously Infected Mice Treated with NRS,
ALS, AMS, ANS, and AES on days -1, 1, 3, 5, and 7.
above that seen in the previously uninfected mice and was significantly higher
than that of the immune controls (P <0.001) .
Recovery ofSchistosomula from the Lungs ofMice Rendered Immune by the
Passive Transfer ofSerum and Effect ofAES . Sera collected from donor mice
with bisexual S. mansoni infections of 16 wk duration transferred partial
resistance to recipient mice . At 6 days the mean recovery of schistosomula after







mean % - SE
Uninfected-untreated 3 64-1 .3 29-1.1 1-0.6 6-0.5
6 57-1.4 34-1.4 3-0.8 6-1 .2
Infected-NRS 3 57-3.1 31±1 .1 15-2.4 0.4-0.1
6 50-t1 .7 36-1.9 12-1.0 2-0.6
Infected-ALS 3 15-1.5 62-3 .2 18±2 .9 5±1.1
6 19-3.1 58-2 .1 15 -2 .3 8-1.4
Infected-AMS 3 36-1.3 50-2 .1 13-2.8 0.4-0.1
6 30-2.7 56-1 .3 14-2 .0 0.7-0 .1
Infected-ANS 3 72-4.0 10-1.2 15-4 .2 3-1.1
6 69-1 .8 12-0.7 12-2 .9 7-2.9
Infected-AES 3 55-2 .0 40-3 .1 1.0-0 .3 4-0.7
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FIG. 2.
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Recovery of schistosomula 6 days after percutaneous exposure to 500 cercariae of
S. mansoni of control, uninfected mice, and partially immune previously infected mice
treated with NRS, ALS, AMS, ANS, and AES.
fected mice plus NRS or AES was 90 ± 6.9 and 96 ± 6 .4, respectively. Mice
injected with serum from the infected mice and treated with NRS showed
significant immunity with a mean recovery of schistosomula of 56 ± 4.5 (P <
0.01). AES treatment nullified the partial resistance to reinfection conferred by
the transfer of immune serum as evidenced by a mean recovery of schistosomula
of 86 -t 5.7 (P < 0.01) .
Recovery ofAdult Worms from the Portal System ofImmune Mice and Effect
ofAES . The worm burden of control mice which had received only the primary
exposure to 10 cercariae 38 wk previously was 4 ± 0 .6. The mice challenged with
100 cercariae at 32 wk and treated with NRS had a worm burden at 38 wk of 16
4.2, which was a mean increment of 12 schistosomes. In contrast, similarly
challenged mice treated with AES had a worm burden 6 wk later of 36 -r 7 .7,
which was a mean increment of 32 schistosomes . The difference between the
NRS- and AES-treated mice was highly significant statistically (P < 0.001).
Previously uninfected control animals exposed to 100 cercariae showed a mean
of 39 ± 9.2 schistosomes 6 wk later.
Discussion
Eosinophilia has been associated with allergic reactions, helminthic infec-
tions, and neoplasms for almost a century. Nevertheless, as Zucker-Franklin
commented in a recent review, "Whether these cells fulfill a detrimental or
beneficial function is still open to question," (18). In the past it was suggested
that eosinophils break down histamine released in the tissues (19), and that they
may be involved in the induction of antibody formation (20) ; these two theories
have not been substantiated. With respect to allergic reactions, an eosinophil
chemotactic factor of anaphylaxis has been described; this material has recently
been found to be released by some neoplasms (21, 22). Eosinophils have also been810 ANTIEOSINOPHIL SERUM AND IMMUNITY TO S . MANSONI INFECTION
shown to be attracted to antigen-antibody complexes (23) and to phagocytize and
destroy these potentially harmful entities (24) . Recently the eosinophilia in-
duced by helminths has been related to cell-mediated mechanisms (25, 26) .
Thus, while there are many potentially harmful or helpful immunological
reactions with which eosinophils have been associated, none of them has been
connected directly either to disease-related hypersensitivity reactions or to
resistance to reinfection .
One of the major tools by which the different types of white cells have been
associated with immunity or immunopathology has been the development of
highly specific antisera against these cells . Thus the availability of ALS has
provided much information about the role of lymphocytes, and even more
specific antisera directed against B or T lymphocytes have added further to our
knowledge (27) . ANS has elucidated the role of the neutrophil in immune
complex reactions (28) . When a monospecific rabbit antimouse eosinophil serum
(AES) was produced in our laboratories (13) it was hoped that it might provide
information on the roles of the eosinophil . This antiserum agglutinated and was
cytotoxic only to eosinophils in vitro and its activity could be absorbed out only
with eosinophils, even the closely related polymorphonuclear neutrophil having
no effect . It was also demonstrated in mice with schistosomiasis and recently in
mice with trichinosis (unpublished data) that a single intraperitoneal injection
ofAES would cause a virtual disappearance of peripheral eosinophils for almost
5 days . Subsequent investigations have been performed on the effect ofAES on
the eosinophilic response to schistosome eggs, the major parasitic factor responsi-
ble for the development of schistosomal disease (29) . Repeated doses of AES
aborted the peripheral eosinophilic response and destroyed the mature eosino-
phils in the bone marrow, but induced the proliferation of eosinophil precursors .
Most important, the granulomatous tissue lesions around the eggs contained no
eosinophils and were consequently considerably reduced in size . This may have
an effect on the rate ofegg destruction, since eosinophils havebeen suggested as
the major phagocytic cells involved in this process (30) . However, the delayed
hypersensitivity-type granulomas (31) in schistosomiasis are made up largely of
macrophage and eosinophil effector cells, and removal of either ofthese cells (15,
29) diminishes the size of the lesion and, thus, the amount of tissue injury .
In the present investigation, we have turned our attention to immunity in
schistosomiasis . Partial resistance to reinfection has been demonstrated in
several species of rodents and primates (1) . Only recently has this resistance
been transferred in vivo and then with serum (4) and not with cells . In vitro
systems involving the cultivation of immature schistosomes (schistosomula)
have demonstrated a direct lethal antibody in antisera from immune animals
(6) . Another system has been described in rats, however, which involves antise-
rum, complement, and neutrophils (3) . Using radiolabeled schistosomula and
human antiserum and cells, an antibody-dependent cell-mediated killing sys-
temhas been reportedby Butterworth et al . (9) . In subsequent studies using our
rabbit antihuman eosinophil and neutrophil sera (32) Butterworth has gained
further evidence that the eosinophil is the effector cell in his elegant in vitro
system (11) . Moreover, indirect evidence that eosinophils may function inimmu-
nity in vivo has recently appeared : a rhesus monkey repeatedly immunized byADEL A . F . MAHMOUD, KENNETH S . WARREN, PIERRE A . PETERS
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X-irradiated cercariae on challenge with normal cercariae showed destruction of
schistosomula associated with large numbers of eosinophils in the skin (33) .
In our system, partially immune mice, as determined by a marked reduction
in the numbers of schistosomula and adult worms, were exposed to AES . This
treatment completely nullified the immunity as demonstrated by restoration to
the numbers seen in control nonimmune mice of the schistosomula passing
through the lungs at three different time periods and of the adult worms in the
portal venous system . The total lack of effect ofANS, AMS, and ALS indicated
that the eosinophil was the only significant effector cell in this in vivo system .
Furthermore, the ineffectiveness ofALS indicated that a specific cell-mediated
immunological reactionwas not involved in the resistance to reinfection evinced
by these animals . This was confirmed when antiserum from 16-wk infected mice
passively transferred resistance to reinfection to uninfected mice ; this immunity
was again nullified by AES .
Thus AES appears to have defined a helpful role for the eosinophil . For the
first time ithas been shown definitively that the eosinophil is an essential factor
in immunity in vivo, in this case, resistance to reinfection by the major hel-
minth parasite of man .
Summary
Partial immunity to schistosomiasis mansoni has been demonstrated in mice
and has recently been transferred passively with serum, but not with cells . In
vitro studies using human and rodent materials have demonstrated antibody-
dependent cell-mediated damage to immature schistosomes (schistosomula) ; the
cell involved in some of these in vitro systems appears to be the neutrophil and
in others the eosinophil is suspected . In the present study the effect of antileuko-
cyte sera on partial immunity to schistosomiasis was tested in vivo using
quantitative assay systems for schistosomula in the lungs and adult worms in
the portal venous system . Mice infected with 10 cercariae of Schistosoma
mansoni 16 and 32 wk before challenge with 500 cercariae showed reductions in
the recovery of schistosomula at 4 and 6 days of approximately 40% ; adult worm
recovery was reduced by 60% . Treatment with antilymphocyte, antimacro-
phage, or antineutrophil serum had no effect on the numbers of schistosomula
recovered from the lungs of immune animals, but in the mice treated with
antieosinophil serum the numbers of schistosomula and adult worms recovered
increased to the levels seen in normal nonimmune animals . Furthermore, sera
collected from the partially immune mice and passively transferred to unin-
fected mice conferred a marked resistance to infection as measured by recovery
of schistosomula ; this was also abrogated by treatment with antieosinophil
serum . These studies suggest that antibody-dependent cell-mediated immunity
to schistosomiasis occurs in vivo, and also establishes a role for the eosinophil in
immune systems .
Received for publication 7 April 1975 .
References
1 . Smithers, S . R ., and R. J . Terry . 1969 . Immunity in schistosomiasis . Ann . N . Y .
Acad . Sci . 160:826 .812 ANTIEOSINOPHIL SERUM AND IMMUNITY TO S . MANSONI INFECTION
2 . Sher, A ., P . Mackenzie, and S. R . Smithers . 1974 . Decreased recovery of invading
parasites from the lungs as a parameter of acquired immunity to schistosomiasis in
the laboratory mouse . J . Infect . Dis . 130:626 .
3 . Dean, D . A ., R . Wistar, and K . D . Murrell . 1974 . Combined in vitro effects of rat
antibody and neutrophilic leukocytes on schistosomula of Schistosoma mansoni .
Am . J . Trop . Med . Hyg . 23:420 .
4 . Sher, A ., S . R . Smithers, and P . Mackenzie . 1975 . Passive transfer of acquired
resistance to Schistosoma mansoni in laboratory mice . Parasitology . 70 :347 .
5 . Capron, A ., M . Capron, H . Dupas, D . Bout, andA . Pettiprez . 1974 . Etude in vitro de
phenomenes immunologiques dans la schistosomaise humaine et experimentale . I .
Etude comparative in vitro de 1'activite lethale d'immunserums sur les formes
immatures et sur les adultes de Schistosoma mansoni . Int . J . Parasitol . 4:613 .
6 . Clegg, J . A ., and S . R. Smithers . 1972 . Effects ofimmune rhesus monkey serum on
schistosomula of Schistosoma mansoni during cultivation in vitro . Int . J . Parasitol .
2:79 .
7 . Maddison, S . E ., S . J . Geiger, B . Botero, and I . G . Kagan . 1970 . Schistosoma
mansoni infection in the rat . 11 . Effects of immunosuppression, and serum and cell
transfer on innate and acquired immunity . J . Parasitol . 56 :1066 .
8 . Dean, D . A ., R . Wistar, and P . Chen . 1975 . Immune responses of guinea pigs to
Schistosoma mansoni . I . In vitro effects of antibody and neutrophils, eosinophils and
macrophages on schistosomula . Am . J . Trop . Med . Hyg . 24:74 .
9 . Butterworth, A . E ., R. F . Sturrock, V . Houba, and P . H . Rees . 1975 . Antibody-
dependen t cell-mediated damage to schistosomula in vitro . Nature (Lond .) . 252:503 .
10 . Mahmoud, A . A . F ., R . W . Kellermeyer, and K . S . Warren . 1974 . Production of
monospecific rabbit antihuman eosinophil serums and demonstration of a blocking
phenomenon .N . Engl . J . Med . 290 :417 .
11 . Butterworth, A . E ., R . F . Sturrock, V . Houba, A . A . F . Mahmoud, A . Sher, and P . H .
Rees . Eosinophils as mediators of antibody-dependent damage to schistosomula .
Nature (Lond .) . In press .
12 . Peters, P . A ., and K . S . Warren . 1969 . A rapid method of infecting mice and other
laboratory animals with Schistosoma mansoni : subcutaneous injection . J . Parasitol .
55:558 .
13 . Mahmoud, A . A . F ., K . S . Warren, and D . L . Boros . 1973 . Production of a rabbit
antimouse eosinophil serum with no cross-reactivity to neutrophils . J . Exp . Med .
137 :1526 .
14 . Simpson, D . M ., and R . Ross . 1971 . Effects of heterologous antineutrophil serum in
guinea pigs . Hematologic and ultrastructural observations .Am .J . Pathol . 65 :249 .
15 . Boros, D . L ., and K . S . Warren . 1971 . Effect of antimacrophage serum on hypersensi-
tivity (Schistosoma mansoni egg) and foreign body (divinyl-benzene copolymer bead)
granulomas . J . Immunol . 107:534 .
16 . Mandel, M . A ., and R . Asofsky . 1968 . The effects of heterologous anti-thymocyte sera
in mice . I . The use of a graft-vs .-host assay as a measure of homograft reactivity . J .
Immunol . 100 :1319 .
17 . Warren, K . S ., and P . A . Peters . 1967 . Comparison of penetration and maturation of
Schistosoma mansoni in the hamster, mouse, guinea pig, rabbit and rat . Am . J .
Trop . Med . Hyg . 16:718 .
18 . Zucker-Franklin, D . 1974 . Eosinophil function and disorders . Adv . Intern . Med . 19:1 .
19 . Archer, R. K . 1970 . Regulatory mechanisms in eosinophil leukocyte production,
release and distribution . In Regulation of Hematopoiesis, Vol . 2 . A . S . Gordon,
editor . Appleton-Century-Crofts, New York . 917 .
20 . Speirs, R . S . 1970 . Function of leukocytes in inflammation and immunity . In Regula-ADEL A . F . MAHMOUD, KENNETH S . WARREN, PIERRE A . PETERS
￿
813
tion of Hematopoiesis, Vol . 2 . A . S . Gordon, editor . Appleton-Century-Crofts, New
York . 995 .
21 . Kay, A . B ., D . T . Stechschulte, and K . F. Austen . 1971 . An eosinophil leukocyte
chemotactic factor of anaphylaxis . J . Exp. Med . 133 :602 .
22 . Wasserman, S . I ., E . J . Goetzel, L . Ellman, and K . F . Austen . 1974 . Tumor-
associated eosinophilotactic factor .N . Engl . J . Med. 290:420 .
23 . Cohen, S ., and P . A . Ward . 1971 . In vitro and in vivo activity of a lymphocyte and
immune complex-dependent chemotactic factor for eosinophils . J . Exp . Med .
133:133 .
24 . Litt, M . 1964 . Studies in experimental eosinophilia . VI . Uptake ofimmune complexes
by eosinophils . J . Cell . Biol . 23:355 .
25 . Basten, A ., and P . B . Beeson . 1970 . Mechanism of eosinophilia . II . Role of the
lymphocytes . J . Exp . Med . 131 :1288 .
26 . Colley, D . G . 1973 . Eosinophils and immune mechanisms . I . Eosinophil stimulation
promoter (ESP) : a lymphokine induced by specific antigen or phytohemagglutinin . J .
Immunol . 110:1419 .
27 . Raff, M . C . 1973 . T and B lymphocytes and immune responses . Nature (Loud .) .
242:19 .
28 . Cochrane, C . G . 1968 . Immunologic tissue injury mediated by neutrophilic leuko-
cytes . Adv . Immunol. 9 :97 .
29 . Mahmoud, A . A . F ., K . S . Warren, and R . C . Graham, Jr . 1975 . Antieosinophil
serum and the kinetics of eosinophilia in Schistosomiasis mansoni . J . Exp . Med.
142:560 .
30 . Colley, D . G ., S . P . Katz, and S . K . Wikel . 1974 . Schistosomiasis : an experimental
model for the study of immunopathologic mechanisms which involve eosinophils .
Adv . Biosci . 12:653 .
31 . Warren, K . S ., E . O . Domingo, and R . B . T . Cowan . 1967 . Granuloma formation
around schistosome eggs as a manifestation of delayed hypersensitivity . Am . J .
Pathol . 51 :735 .
32 . Mahmoud, A . A . F ., R . W . Kellermeyer, and K . S . Warren . 1974 . Monospecific
antigranulocyte sera against human neutrophils, eosinophils, basophils and myelo-
blasts . Lancet . 2:1163 .
33 . Hsu, S . Y . L ., H . F . Hsu, G . D . Penick, G. L . Lust, and J . W . Osborne . 1974 . Derma l
hypersensitivity to schistosome cercariae in rhesus monkeys during immunization
and challenge . I . Complex hypersensitivity reactions of a well-immunized monkey
during the challenge . J . Allergy Clin . Immunol . 54:339 .